{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T06:29:59Z","timestamp":1795069799644,"version":"4.10.2"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T00:00:00Z","timestamp":1746576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The global evidence on the risk of symptoms of Long Covid in general populations infected with SARS-CoV-2 compared to uninfected comparator\/control populations remains unknown. We conducted a systematic literature search using multiple electronic databases from January 1, 2022, to August 1, 2024. Included studies had \u2265100 people with confirmed or self-reported COVID-19 at \u226528 days following infection onset, and an uninfected comparator\/control group. Results were summarised descriptively and meta-analyses were conducted to derive pooled risk ratio estimates. 50 studies totaling 14,661,595 people were included. In all populations combined, there was an increased risk of a wide range of 39 out of 40 symptoms in those infected with SARS\u2011CoV\u20112 compared to uninfected controls. The symptoms with the highest pooled relative risks were loss of smell (RR 4.31; 95% CI 2.66, 6.99), loss of taste (RR 3.71; 95% CI 2.22, 7.26), poor concentration (RR 2.68; 95% CI 1.66, 4.33), impaired memory (RR 2.53; 95% CI 1.82, 3.52), and hair loss\/alopecia (RR 2.38; 95% CI 1.69, 3.33). This evidence synthesis, of 50 controlled studies with a cumulative participant count exceeding 14 million people, highlights a significant risk of diverse long-term symptoms in individuals infected with SARS-CoV-2, especially among those who were hospitalised.<\/jats:p>","DOI":"10.1038\/s41467-025-59012-w","type":"journal-article","created":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T15:48:43Z","timestamp":1746632923000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["The risk of Long Covid symptoms: a systematic review and meta-analysis of controlled studies"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2786-3290","authenticated-orcid":false,"given":"Lauren L.","family":"O\u2019Mahoney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5651-4228","authenticated-orcid":false,"given":"Ash","family":"Routen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian A.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6035-1230","authenticated-orcid":false,"given":"Abdullah","family":"Almaqhawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6352-0394","authenticated-orcid":false,"given":"Daniel","family":"Ayoubkhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8741-3411","authenticated-orcid":false,"given":"Amitava","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Brightling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1856-837X","authenticated-orcid":false,"given":"Melanie","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6201-9063","authenticated-orcid":false,"given":"Shabana","family":"Cassambai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winifred","family":"Ekezie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7473-5999","authenticated-orcid":false,"given":"Mark P.","family":"Funnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneka","family":"Welford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arron","family":"Peace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1667-868X","authenticated-orcid":false,"given":"Rachael A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7542-1772","authenticated-orcid":false,"given":"Shavez","family":"Jeffers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Kingsnorth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Pareek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Seidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2729-4961","authenticated-orcid":false,"given":"Roz","family":"Shafran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8871-7847","authenticated-orcid":false,"given":"Terence","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8496-6053","authenticated-orcid":false,"given":"Jonathan","family":"Sterne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8238-5036","authenticated-orcid":false,"given":"Helen","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2748-4063","authenticated-orcid":false,"given":"Tom","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2343-7099","authenticated-orcid":false,"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,7]]},"reference":[{"key":"59012_CR1","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1001\/jama.2022.18931","volume":"328","author":"Collaborators, G.B.o.D.L.C.","year":"2022","unstructured":"Collaborators, G.B.o.D.L.C. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 328, 1604\u20131615 (2022).","journal-title":"JAMA"},{"key":"59012_CR2","doi-asserted-by":"crossref","unstructured":"O\u2019Mahoney, L. L. et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine 55, 101762 (2023).","DOI":"10.1016\/j.eclinm.2022.101762"},{"key":"59012_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-023-02250-0","volume":"12","author":"A Natarajan","year":"2023","unstructured":"Natarajan, A. et al. A systematic review and meta-analysis of long COVID symptoms. Syst. Rev. 12, 88 (2023).","journal-title":"Syst. Rev."},{"key":"59012_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1177\/01410768211032850","volume":"114","author":"OL Aiyegbusi","year":"2021","unstructured":"Aiyegbusi, O. L. et al. Symptoms, complications and management of long COVID: a review. J. R. Soc. Med. 114, 428\u2013442 (2021).","journal-title":"J. R. Soc. Med."},{"key":"59012_CR5","doi-asserted-by":"publisher","first-page":"e005427","DOI":"10.1136\/bmjgh-2021-005427","volume":"6","author":"M Michelen","year":"2021","unstructured":"Michelen, M. et al. Characterising long COVID: a living systematic review. BMJ Glob. Health 6, e005427 (2021).","journal-title":"BMJ Glob. Health"},{"key":"59012_CR6","doi-asserted-by":"crossref","unstructured":"Lopez-Leon, S. et al. More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep. 11, 16144 (2021).","DOI":"10.1038\/s41598-021-95565-8"},{"key":"59012_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad233","volume":"10","author":"M Woodrow","year":"2023","unstructured":"Woodrow, M. et al. Systematic review of the prevalence of long COVID. Open Forum Infect. Dis. 10, ofad233 (2023).","journal-title":"Open Forum Infect. Dis."},{"key":"59012_CR8","doi-asserted-by":"publisher","first-page":"e1713","DOI":"10.1016\/S2214-109X(23)00384-4","volume":"11","author":"SA M\u00fcller","year":"2023","unstructured":"M\u00fcller, S. A. et al. Prevalence and risk factors for long COVID and post-COVID-19 condition in Africa: a systematic review. Lancet Glob. Health 11, e1713\u2013e1724 (2023).","journal-title":"Lancet Glob. Health"},{"key":"59012_CR9","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s11739-022-03164-w","volume":"18","author":"F Di Gennaro","year":"2023","unstructured":"Di Gennaro, F. et al. Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients. Intern. Emerg. Med. 18, 1573\u20131581 (2023).","journal-title":"Intern. Emerg. Med."},{"key":"59012_CR10","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.jiph.2023.03.005","volume":"16","author":"Y-B Zheng","year":"2023","unstructured":"Zheng, Y.-B. et al. Prevalence and risk factor for long COVID in children and adolescents: a meta-analysis and systematic review. J. Infect. Public Health 16, 660\u2013672 (2023).","journal-title":"J. Infect. Public Health"},{"key":"59012_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28852","volume":"95","author":"M Rahmati","year":"2023","unstructured":"Rahmati, M. et al. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: a call to action for neurological, physical, and psychological sciences. J. Med. Virol. 95, e28852 (2023).","journal-title":"J. Med. Virol."},{"key":"59012_CR12","doi-asserted-by":"publisher","first-page":"e2128568","DOI":"10.1001\/jamanetworkopen.2021.28568","volume":"4","author":"D Groff","year":"2021","unstructured":"Groff, D. et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw. Open 4, e2128568\u2013e2128568 (2021).","journal-title":"JAMA Netw. Open"},{"key":"59012_CR13","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jval.2022.11.011","volume":"26","author":"Q Huang","year":"2023","unstructured":"Huang, Q. et al. One-year temporal changes in long COVID prevalence and characteristics: a systematic review and meta-analysis. Value Health 26, 934\u2013942 (2023).","journal-title":"Value Health"},{"key":"59012_CR14","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.52225\/narraj.v1i2.36","volume":"1","author":"M Fahriani","year":"2021","unstructured":"Fahriani, M. et al. Persistence of long COVID symptoms in COVID-19 survivors worldwide and its potential pathogenesis - A systematic review and meta-analysis. Narra J. 1, e36 (2021).","journal-title":"Narra J."},{"key":"59012_CR15","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/pathogens11020269","volume":"11","author":"Q Han","year":"2022","unstructured":"Han, Q., Zheng, B., Daines, L. & Sheikh, A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens 11, 269 (2022).","journal-title":"Pathogens"},{"key":"59012_CR16","first-page":"e36325","volume":"15","author":"SK Mudgal","year":"2023","unstructured":"Mudgal, S. K. et al. Pooled prevalence of long COVID-19 symptoms at 12 months and above follow-up period: a systematic review and meta-analysis. Cureus 15, e36325 (2023).","journal-title":"Cureus"},{"key":"59012_CR17","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","volume":"226","author":"C Chen","year":"2022","unstructured":"Chen, C. et al. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J. Infect. Dis. 226, 1593\u20131607 (2022).","journal-title":"J. Infect. Dis."},{"key":"59012_CR18","doi-asserted-by":"publisher","first-page":"e065234","DOI":"10.1136\/bmjopen-2022-065234","volume":"12","author":"A Al-Oraibi","year":"2022","unstructured":"Al-Oraibi, A. et al. Prevalence of long COVID-19 among healthcare workers: a systematic review and meta-analysis protocol. BMJ Open 12, e065234 (2022).","journal-title":"BMJ Open"},{"key":"59012_CR19","doi-asserted-by":"publisher","first-page":"220254","DOI":"10.1183\/16000617.0254-2022","volume":"32","author":"JD Kelly","year":"2023","unstructured":"Kelly, J. D. et al. SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis. Eur. Respir. Rev. 32, 220254 (2023).","journal-title":"Eur. Respir. Rev."},{"key":"59012_CR20","doi-asserted-by":"publisher","first-page":"220071","DOI":"10.1183\/16000617.0071-2022","volume":"31","author":"Z Bang","year":"2022","unstructured":"Bang, Z. et al. Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis. Eur. Respir. Rev. 31, 220071 (2022).","journal-title":"Eur. Respir. Rev."},{"key":"59012_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jinf.2021.11.011","volume":"84","author":"SA Behnood","year":"2022","unstructured":"Behnood, S. A. et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: a meta-analysis of controlled and uncontrolled studies. J. Infect. 84, 158\u2013170 (2022).","journal-title":"J. Infect."},{"key":"59012_CR22","doi-asserted-by":"publisher","first-page":"e0250909","DOI":"10.1371\/journal.pone.0250909","volume":"18","author":"H Hoshijima","year":"2023","unstructured":"Hoshijima, H. et al. Incidence of long-term post-acute sequelae of SARS-CoV-2 infection related to pain and other symptoms: a systematic review and meta-analysis. PLoS ONE 18, e0250909 (2023).","journal-title":"PLoS ONE"},{"key":"59012_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-42321-9","volume":"13","author":"Z Marjenberg","year":"2023","unstructured":"Marjenberg, Z. et al. Risk of long COVID main symptoms after SARS-CoV-2 infection: a systematic review and meta-analysis. Sci. Rep. 13, 15332 (2023).","journal-title":"Sci. Rep."},{"key":"59012_CR24","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.14.05022","volume":"14","author":"Z Xu","year":"2024","unstructured":"Xu, Z. et al. Excess risks of long COVID symptoms compared with identical symptoms in the general population: a systematic review and meta-analysis of studies with control groups. J. Glob. Health 14, 05022 (2024).","journal-title":"J. Glob. Health"},{"key":"59012_CR25","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1136\/bmj.316.7136.989","volume":"316","author":"HT Davies","year":"1998","unstructured":"Davies, H. T., Crombie, I. K. & Tavakoli, M. When can odds ratios mislead? BMJ 316, 989\u2013991 (1998).","journal-title":"BMJ"},{"key":"59012_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01402-2","volume":"23","author":"LJ Stovner","year":"2022","unstructured":"Stovner, L. J., Hagen, K., Linde, M. & Steiner, T. J. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J. Headache Pain. 23, 34 (2022).","journal-title":"J. Headache Pain."},{"key":"59012_CR27","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2213-2600(22)00169-2","volume":"10","author":"D Munblit","year":"2022","unstructured":"Munblit, D. et al. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study. Lancet Respir. Med. 10, 715\u2013724 (2022).","journal-title":"Lancet Respir. Med."},{"key":"59012_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S2213-2600(22)00127-8","volume":"10","author":"RA Evans","year":"2022","unstructured":"Evans, R. A. et al. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir. Med. 10, 761\u2013775 (2022).","journal-title":"Lancet Respir. Med."},{"key":"59012_CR29","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.3390\/children10071227","volume":"10","author":"SM Pinto Pereira","year":"2023","unstructured":"Pinto Pereira, S. M. et al. Symptom profiles of children and young people 12 months after SARS-CoV-2 testing: a national matched cohort study (The CLoCk Study). Children 10, 1227 (2023).","journal-title":"Children"},{"key":"59012_CR30","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S2352-4642(22)00022-0","volume":"6","author":"T Stephenson","year":"2022","unstructured":"Stephenson, T. et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc. Health 6, 230\u2013239 (2022).","journal-title":"Lancet Child Adolesc. Health"},{"key":"59012_CR31","unstructured":"World Health Organisation. Post COVID-19 condition (Long COVID). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/post-covid-19-condition-(long-covid) (2025)."},{"key":"59012_CR32","doi-asserted-by":"publisher","first-page":"e0277704","DOI":"10.1371\/journal.pone.0277704","volume":"18","author":"T Stephenson","year":"2023","unstructured":"Stephenson, T. et al. Long COVID\u2014six months of prospective follow-up of changes in symptom profiles of non-hospitalised children and young people after SARS-CoV-2 testing: a national matched cohort study (The CLoCk) study. PLoS ONE 18, e0277704 (2023).","journal-title":"PLoS ONE"},{"key":"59012_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2022.100554","volume":"25","author":"SM Pinto Pereira","year":"2023","unstructured":"Pinto Pereira, S. M. et al. Natural course of health and well-being in non-hospitalised children and young people after testing for SARS-CoV-2: a prospective follow-up study over 12 months. Lancet Reg. Health Eur. 25, 100554 (2023).","journal-title":"Lancet Reg. Health Eur."},{"key":"59012_CR34","unstructured":"World Health Organisation. A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1 (2023)."},{"key":"59012_CR35","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539\u20131558 (2002).","journal-title":"Stat. Med."},{"key":"59012_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"E Matthias","year":"1997","unstructured":"Matthias, E., George Davey, S., Martin, S. & Christoph, M. Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629 (1997).","journal-title":"BMJ"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59012-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59012-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59012-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,7]],"date-time":"2025-05-07T15:48:50Z","timestamp":1746632930000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-59012-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,7]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["59012"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-59012-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,7]]},"assertion":[{"value":"29 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.B. is PI of the NIHR-funded STIMULATE-ICP study (COV-LT2-0043) and has also received other research funding from Astra Zeneca, NIHR, BMA, UKRI and EU. M.C. is Director of the Birmingham Health Partners Centre for Regulatory Science and Innovation, Director of the Centre for Patient Reported Outcomes Research and is a National Institute for Health Research (NIHR) Senior Investigator. MC receives funding from the National Institute for Health Research (NIHR), UK Research and Innovation (UKRI), NIHR Birmingham Biomedical Research Centre, the NIHR Surgical Reconstruction and Microbiology Research Centre, NIHR ARC West Midlands, UK SPINE, European Regional Development Fund \u2013 Demand Hub and Health Data Research UK at the University of Birmingham and University Hospitals Birmingham NHS Foundation Trust, Innovate UK (part of UKRI), Macmillan Cancer Support, UCB Pharma, Janssen, GSK and Gilead. She is the senior author of the Symptom Burden Questionnaire\u2122 for Long COVID. M.C. has received personal fees from Aparito Ltd, CIS Oncology, Takeda, Merck, Daiichi Sankyo, Glaukos, GSK and the Patient-Centered Outcomes Research Institute (PCORI) outside the submitted work. In addition, a family member owns shares in GSK. All research at Great Ormond Street Hospital NHS Foundation Trust and UCL Great Ormond Street Institute of Child Health is made possible by the NIHR Great Ormond Street Hospital Biomedical Research Centre. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health (R.S. and T.S.). T.S. is Chair of the Health Research Authority for England and recused himself from all Research Ethics Applications. H.W. is an NIHR Senior Investigator Award and acknowledges support from the NIHR Imperial Biomedical Research Centre, Health Data Research UK, NIHR Applied Research Collaborative North West London, and the Wellcome Trust. K.K. is Chair of the Ethnicity Subgroup of the UK Scientific Advisory Group for Emergencies (SAGE) and Member of SAGE and also Chair of the National Long Covid Research Working Group which informs the Chief Medical Officer. K.K. has acted as a consultant, speaker or received grants for investigator-initiated studies for Astra Zeneca, Sanofi-Aventis, Pfizer and Roche. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4249"}}